| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |